Chromosomal rearrangements between the androgen-regulated gene, TMPRSS2, and the oncogenic ETS transcription factor gene, ERG, occurs in approximately 30–50% of prostate cancers (PRAD) [34]. The gene discussed is ERG; the disease is prostate adenocarcinoma.